|
PM577a Clinical Trials
1 actively recruiting trial across 1 location
No change since September 2026
Pipeline
Phase 1/2: 1
Top Sponsors
- Prime Medicine, Inc.1
Indications
- Wilsons Disease1
- Wilson's Disease1
- Liver Disease1
- Wilson Disease1
New Haven, Connecticut1 trial
A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
Yale New Haven Hospital
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.